Wave Life Sciences Ltd. (NASDAQ:WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced the approval of its first clinical trial
Wave Life Sciences Ltd (NASDAQ: WVE) has priced its previously announced underwritten public offering of 20 million shares at $5.00 per share with approximately
Shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) jumped in pre-market trading after AbbVie Inc. (NYSE: ABBV) announced it will acquire the company for a total equity value of approximately $8.7 billion.
U.S. stock futures traded mixed this morning, with the Dow Jones futures falling around 70 points on Thursday.
Shares of Sprinklr, Inc. (NYSE: CXM) shares fell sharply in pre-market trading following weak earnings for the third quarter.